140 related articles for article (PubMed ID: 22827468)
1. Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study.
Milan M; Noventa F; Ghirarduzzi A; Pengo V; Vedovetto V; Filippi L; Campello E; Prandoni P
J Thromb Haemost; 2012 Oct; 10(10):2205-6. PubMed ID: 22827468
[No Abstract] [Full Text] [Related]
2. Aspirin and recurrent venous thromboembolism.
Prandoni P; Noventa F; Milan M
Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Is Associated With Reduced Rates of Venous Thromboembolism in Older Patients With Cancer.
Li P; Ning Y; Li M; Cai P; Siddiqui AD; Liu EY; Hadley M; Wu F; Pan S; Dixon RAF; Liu Q
J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):456-465. PubMed ID: 32400177
[TBL] [Abstract][Full Text] [Related]
4. Use of ASA after warfarin for unprovoked VTE.
Allan GM; Banh HL; Ference J
Can Fam Physician; 2013 Oct; 59(10):1075. PubMed ID: 24130282
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
Schousboe JT; Brown GA
J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
[TBL] [Abstract][Full Text] [Related]
6. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for long term maintenance therapy of venous thromboembolism.
Schellong S
Vasa; 2013 Mar; 42(2):83-5. PubMed ID: 23485833
[No Abstract] [Full Text] [Related]
8. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.
De Stefano V; Finazzi G; Barbui T
Blood Cancer J; 2018 Jun; 8(7):65. PubMed ID: 29946112
[TBL] [Abstract][Full Text] [Related]
10. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Goldhaber SZ; Eriksson H; Kakkar A; Schellong S; Feuring M; Fraessdorf M; Kreuzer J; Schueler E; Schulman S
Vasc Med; 2016 Dec; 21(6):506-514. PubMed ID: 27807306
[TBL] [Abstract][Full Text] [Related]
12. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.
Thijs VN; Albers GW
Neurology; 2000 Aug; 55(4):490-7. PubMed ID: 10953179
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study.
Spencer FA; Gore JM; Reed G; Lessard D; Pacifico L; Emery C; Crowther MA; Goldberg RJ
Thromb Haemost; 2009 May; 101(5):878-85. PubMed ID: 19404541
[TBL] [Abstract][Full Text] [Related]
16. Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients.
Gauthier K; Kovacs MJ; Wells PS; Le Gal G; Rodger M;
J Thromb Haemost; 2013 Jan; 11(1):200-3. PubMed ID: 23114022
[No Abstract] [Full Text] [Related]
17. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
Kopolovic I; Lee AY; Wu C
Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
[TBL] [Abstract][Full Text] [Related]
18. [Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].
Delluc A; Lacut K; Mottier D
Rev Med Interne; 2013 Feb; 34(2):69-72. PubMed ID: 23154111
[No Abstract] [Full Text] [Related]
19. Current therapeutic strategies and future perspectives for the treatment of venous thromboembolism.
Garcia DA
Curr Pharm Des; 2010; 16(31):3475-7. PubMed ID: 20858181
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study.
Sahut D'Izarn M; Caumont Prim A; Planquette B; Revel MP; Avillach P; Chatellier G; Sanchez O; Meyer G
J Thromb Haemost; 2012 Oct; 10(10):2032-8. PubMed ID: 22845852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
